featured
Long-Term Efficacy and Safety of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
Circulation 2024 Nov 18;[EPub Ahead of Print], DP Judge, JD Gillmore, KM Alexander, AV Ambardekar, F Cappelli, M Fontana, P García-Pavía, JL Grodin, M Grogan, M Hanna, A Masri, J Nativi-Nicolau, L Obici, S Hvitfeldt Poulsen, N Sarswat, K Shah, P Soman, T Lystig, X Cao, K Wang, ML Pecoraro, JF Tamby, L Katz, U Sinha, JC Fox, MS MaurerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.